This article explains how the Kato-Katz stool test works, how its egg counts are turned into the World Health Organization's categories of light, moderate and heavy infection, and why the test often misses light infections. It then looks at why that matters for mebendazole. This common deworming medicine is judged largely by Kato-Katz results. The test has built-in limits, and those limits change what "cure" really means in a study. A reader who understands them will be better equipped to talk with a physician about testing and treatment.

What the Kato-Katz test is and how it works

The Kato-Katz technique is a thick-smear method for finding and counting parasite eggs in stool. It began with the work of Japanese researchers Kato and Miura in the 1950s. In 1972, Naftale Katz and colleagues in Brazil standardised it in a paper in the Revista do Instituto de Medicina Tropical de São Paulo, originally for schistosomiasis. It has since become the reference field method for the three main soil-transmitted helminths: the large roundworm (Ascaris lumbricoides), the whipworm (Trichuris trichiura) and the hookworms (Necator americanus and Ancylostoma duodenale).

The procedure is simple, which explains why it is so widely used:

The method is cheap and needs little equipment. It gives a number rather than a simple yes or no. That number is its main strength and also the source of its weaknesses.

How egg counts are translated into infection intensity

Egg output roughly tracks the number of adult worms living in the intestine. The worm burden in turn drives most of the harm: blood loss and iron-deficiency anaemia with hookworm, dysentery-like illness with heavy whipworm, and intestinal obstruction or poor nutrition with heavy roundworm. For this reason, the WHO set intensity thresholds in a 2002 expert committee report on schistosomiasis and soil-transmitted helminthiasis. Those thresholds remain the standard today:

The thresholds differ so much because each species lays eggs at a very different rate. A single female roundworm can produce on the order of two hundred thousand eggs a day, far more than a hookworm. A moderate hookworm count can therefore reflect a burden that matters more to health than a much larger roundworm count. Programmes use these categories to decide how often communities should receive mass treatment. They also use them to track whether morbidity is falling, which is arguably a better measure of success than prevalence alone.

Why light infections slip through

The test's mathematics creates its first blind spot. Because one slide examines only about 42 milligrams of stool, a single egg represents 24 EPG. That is the lowest level a single slide can detect. Below it, a person can be infected and still have no egg on the slide. Several further factors make the problem worse:

Studies consistently show the result. A 2014 systematic review and meta-analysis in the International Journal for Parasitology by Nikolay, Brooker and Pullan of the London School of Hygiene & Tropical Medicine pooled diagnostic studies. It found that a single Kato-Katz slide misses a substantial share of infections for roundworm and hookworm, and fewer for whipworm. Most importantly, sensitivity fell sharply in low-intensity settings. Field work from groups at the Swiss Tropical and Public Health Institute, including studies in Zanzibar and Côte d'Ivoire published in PLoS Neglected Tropical Diseases, reached the same conclusion. Examining several slides from stool collected on several days detects noticeably more infections than a single slide from a single day. The evidence here is strong and consistent across countries and research groups. The mechanism is also well understood, which is why the finding is not seriously disputed.

More sensitive methods exist. Flotation-based techniques such as FLOTAC and Mini-FLOTAC, developed at the University of Naples, examine larger stool volumes. Quantitative polymerase chain reaction (qPCR) detects parasite DNA rather than intact eggs. In comparative studies, qPCR generally identifies considerably more light infections than Kato-Katz. That is one reason large research efforts aimed at interrupting transmission, such as the DeWorm3 trials, have used molecular testing. These methods cost more and need laboratory infrastructure. Kato-Katz therefore remains the practical workhorse in most endemic regions.

What this means for mebendazole

Mebendazole is a synthetic benzimidazole medicine. It works by binding to the worm's beta-tubulin, a protein used to build the microtubules that cells depend on for structure and nutrient uptake. The drug binds the parasite's tubulin far more readily than our own. That selectivity, together with poor absorption from the gut, keeps the medicine concentrated where the worms live and accounts for its generally good safety record. In mass drug administration it is typically given as a single 500 mg chewable tablet. Longer courses, such as 100 mg twice daily for three days, are used in some clinical settings. In the United States, mebendazole is approved for intestinal roundworm, whipworm, hookworm and pinworm infections. Other uses sometimes discussed online, including cancer, are not approved and rest mainly on laboratory and animal research.

Almost everything we know about how well mebendazole works comes from comparing Kato-Katz egg counts before and after treatment. A widely cited 2008 meta-analysis in JAMA by Jennifer Keiser and Jürg Utzinger of the Swiss Tropical Institute reported these pooled single-dose cure rates for mebendazole:

Single-dose albendazole did better against hookworm, at about 72%. A later network meta-analysis by Moser, Schindler and Keiser in the BMJ in 2017 confirmed the same broad pattern: mebendazole is excellent against roundworm and markedly weaker against whipworm and hookworm as a single dose.

The detection problem matters most at this point. After treatment, surviving worms are fewer and egg counts drop, often into the range where Kato-Katz becomes unreliable. A child who still carries a few worms may produce a negative slide and be counted as "cured." Researchers therefore expect cure rates measured with a single Kato-Katz slide to overestimate true cure, especially for hookworm, where egg disintegration adds to the undercount. For this reason, many experts prefer the egg reduction rate, the percentage fall in average egg count, as the main measure of drug efficacy. A multi-country study coordinated by Ghent University and published in PLoS Neglected Tropical Diseases in the early 2010s helped standardise this approach. It also established reference values for judging whether benzimidazoles are still working as expected.

Two practical points follow for patients and families:

Light infection is not the same as no concern

Light infections cause less illness than heavy ones, and the intensity categories rightly direct attention to those most at risk. But every infected person matters, and light infections carry real significance. They sustain transmission in a community by continuing to seed soil with eggs. Children may also slide back into heavier burdens if reinfection continues. As deworming programmes succeed and heavy infections become rare, a larger share of the remaining infections are light. Those are exactly the infections the standard test is worst at finding. A programme may then appear to have finished its work when it has not.

Pregnancy deserves particular thought. The WHO recommends preventive deworming for pregnant women in endemic areas after the first trimester, because hookworm-related anaemia can harm both mother and unborn child. Mebendazole is generally avoided in the first trimester out of caution for the developing baby. That balance reflects care for two lives at once, and it is a decision to make with one's own physician.

Testing in everyday clinical practice

Outside endemic regions, a doctor evaluating a returning traveller, an adopted child or a recent immigrant usually orders a standard "ova and parasites" examination using a concentration method, not Kato-Katz. The same principle applies, though. Because eggs are shed irregularly, clinicians commonly request more than one sample on separate days. A physician may also check a blood count for eosinophilia, which can suggest parasitic infection. Families can do their part by collecting samples as instructed and delivering them promptly. They can also mention travel or exposure history openly and ask whether a follow-up test is sensible after treatment. Simple habits remain the first line of protection: wearing shoes where hookworm is common, washing hands, and safe food and water practices.

The design of the human body gives some reassurance here. The immune system, the gut's barriers and the body's recovery once a worm burden is removed are part of how we are made to heal. Good diagnostics and sound medicine work alongside that design.

Key takeaway: The Kato-Katz test is a valuable, practical way to grade worm infections, but a single slide routinely misses light infections, so mebendazole "cure" rates should be read with care and questions about repeat testing are best discussed with your own physician.